Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
Patricia Dauer, Alice Nomura, Ashok Saluja, et al.
Pancreatology (2016) Vol. 17, Iss. 1, pp. 7-12
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Chemoresistance in Pancreatic Cancer
Siyuan Zeng, Marina Pöttler, Bin Lan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4504-4504
Open Access | Times Cited: 508
Pancreatic Cancer Chemoresistance to Gemcitabine
Manoj Amrutkar, Ivar P. Gladhaug
Cancers (2017) Vol. 9, Iss. 11, pp. 157-157
Open Access | Times Cited: 401
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Dimakatso Alice Senthebane, Arielle Rowe, Nicholas Ekow Thomford, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 7, pp. 1586-1586
Open Access | Times Cited: 369
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 308
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Zhen Luo, Mingfu Tian, Ge Yang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 244
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
Luman Liu, Prakash Kshirsagar, Shailendra K. Gautam, et al.
Theranostics (2022) Vol. 12, Iss. 3, pp. 1030-1060
Open Access | Times Cited: 82
Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going
Chen Liang, Si Shi, Qingcai Meng, et al.
Experimental & Molecular Medicine (2017) Vol. 49, Iss. 12, pp. e406-e406
Open Access | Times Cited: 137
The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma
Yaojie Fu, Shanshan Liu, Shan Zeng, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 123
Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives
Elina Khatoon, Kishore Banik, Choudhary Harsha, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 306-339
Closed Access | Times Cited: 123
Hypoxia alters the release and size distribution of extracellular vesicles in pancreatic cancer cells to support their adaptive survival
Mary C. Patton, Haseeb Zubair, Mohammad Aslam Khan, et al.
Journal of Cellular Biochemistry (2019) Vol. 121, Iss. 1, pp. 828-839
Open Access | Times Cited: 113
The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer
Sandra Valle, Laura Martín-Hijano, Sonia Alcalá, et al.
Cancers (2018) Vol. 10, Iss. 2, pp. 33-33
Open Access | Times Cited: 109
Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer
Xiao Jin, Lu Dai, Yilan Ma, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 100
ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness”
Patricia Dauer, Nikita Sharma, Vineet K. Gupta, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 2
Open Access | Times Cited: 90
Emerging roles for the IL-6 family of cytokines in pancreatic cancer
Gemma van Duijneveldt, Michael D. W. Griffin, Tracy L. Putoczki
Clinical Science (2020) Vol. 134, Iss. 16, pp. 2091-2115
Open Access | Times Cited: 87
Mechanisms for Tuning Engineered Nanomaterials to Enhance Radiation Therapy of Cancer
Sandhya Clement, Jared M. Campbell, Wei Deng, et al.
Advanced Science (2020) Vol. 7, Iss. 24
Open Access | Times Cited: 74
M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
Yongmei Zhao, Yuan‐Lin Zheng, Yan Zhu, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1493-1493
Open Access | Times Cited: 73
Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
Sophie Liot, Jonathan Balas, Alexandre Aubert, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 68
The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
Paul Manoukian, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 61
Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer
Vineet K. Gupta, Nikita Sharma, Brittany Durden, et al.
Cancer Research (2021) Vol. 81, Iss. 15, pp. 4001-4013
Open Access | Times Cited: 58
Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway
Wenpeng Cao, Zhirui Zeng, Zhiwei He, et al.
Aging (2021) Vol. 13, Iss. 5, pp. 7120-7132
Open Access | Times Cited: 57
The role of metabolic reprogramming in pancreatic cancer chemoresistance
Chang Liu, Changfeng Li, Yuanda Liu
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 23
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer
Abigail C. Cornwell, Arwen A. Tisdale, Swati Venkat, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 18, pp. 3793-3812
Open Access | Times Cited: 23
Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions
Guido Giordano, Massimo Pancione, Nunzio Olivieri, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 32, pp. 5875-5875
Open Access | Times Cited: 80
Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer
Nagaraj S. Nagathihalli, Jason Castellanos, Purushottam Lamichhane, et al.
Cancer Research (2018) Vol. 78, Iss. 21, pp. 6235-6246
Open Access | Times Cited: 78
The Role of Exosomes in Pancreatic Cancer
Bin Lan, Siyuan Zeng, Robert Grützmann, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4332-4332
Open Access | Times Cited: 75
Page 1 - Next Page

Scroll to top